n. a drug, related to thalidomide, that affects the immune response and has activity against tumour cell formation and angiogenesis. It is used to treat multiple myeloma and certain types of myelodysplastic syndromes. It is taken by mouth; the most serious side-effects are deep vein thrombosis and neutropenia, and there is a risk of teratogenesis (women capable of bearing children must practise contraception during treatment and for a month before and after it). Trade name: Revlimid.
Subjects: Clinical Pharmacology and Therapeutics.